{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:28:14Z","timestamp":1791872894245,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009978","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000}}],"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["21170501"],"award-info":[{"award-number":["21170501"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["21170427"],"award-info":[{"award-number":["21170427"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["21170968"],"award-info":[{"award-number":["21170968"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["FONDECYT 3210667"],"award-info":[{"award-number":["FONDECYT 3210667"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["FONDECYT 1190341"],"award-info":[{"award-number":["FONDECYT 1190341"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["FONDECYT 3180452"],"award-info":[{"award-number":["FONDECYT 3180452"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["FONDECYT 1210627"],"award-info":[{"award-number":["FONDECYT 1210627"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"crossref","award":["FONDECYT 1210359"],"award-info":[{"award-number":["FONDECYT 1210359"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq: 305894\/2018-8"],"award-info":[{"award-number":["CNPq: 305894\/2018-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["REDE-00140-16"],"award-info":[{"award-number":["REDE-00140-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Science and Technology in Dengue and Host-microbial interactions","award":["APQ-03606-17"],"award-info":[{"award-number":["APQ-03606-17"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chagas disease, caused by the protozoan\n                      <jats:italic>Trypanosoma cruzi<\/jats:italic>\n                      , is endemic in Latin America and is widely distributed worldwide because of migration. In 30% of cases, after years of infection and in the absence of treatment, the disease progresses from an acute asymptomatic phase to a chronic inflammatory cardiomyopathy, leading to heart failure and death. An inadequate balance in the inflammatory response is involved in the progression of chronic Chagas cardiomyopathy. Current therapeutic strategies cannot prevent or reverse the heart damage caused by the parasite. Aspirin-triggered resolvin D1 (AT-RvD1) is a pro-resolving mediator of inflammation that acts through N-formyl peptide receptor 2 (FPR2). AT-RvD1 participates in the modification of cytokine production, inhibition of leukocyte recruitment and efferocytosis, macrophage switching to a nonphlogistic phenotype, and the promotion of healing, thus restoring organ function. In the present study, AT-RvD1 is proposed as a potential therapeutic agent to regulate the pro-inflammatory state during the early chronic phase of Chagas disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/Principal findings<\/jats:title>\n                    <jats:p>\n                      C57BL\/6 wild-type and FPR2 knock-out mice chronically infected with\n                      <jats:italic>T<\/jats:italic>\n                      .\n                      <jats:italic>cruzi<\/jats:italic>\n                      were treated for 20 days with 5 \u03bcg\/kg\/day AT-RvD1, 30 mg\/kg\/day benznidazole, or the combination of 5 \u03bcg\/kg\/day AT-RvD1 and 5 mg\/kg\/day benznidazole. At the end of treatment, changes in immune response, cardiac tissue damage, and parasite load were evaluated. The administration of AT-RvD1 in the early chronic phase of\n                      <jats:italic>T<\/jats:italic>\n                      .\n                      <jats:italic>cruzi<\/jats:italic>\n                      infection regulated the inflammatory response both at the systemic level and in the cardiac tissue, and it reduced cellular infiltrates, cardiomyocyte hypertrophy, fibrosis, and the parasite load in the heart tissue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions\/Significance<\/jats:title>\n                    <jats:p>\n                      AT-RvD1 was shown to be an attractive therapeutic due to its regulatory effect on the inflammatory response at the cardiac level and its ability to reduce the parasite load during early chronic\n                      <jats:italic>T<\/jats:italic>\n                      .\n                      <jats:italic>cruzi<\/jats:italic>\n                      infection, thereby preventing the chronic cardiac damage induced by the parasite.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0009978","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T13:35:41Z","timestamp":1637069741000},"page":"e0009978","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8957-1955","authenticated-orcid":true,"given":"Ileana","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayane Aparecida Nonato","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Rates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-3138","authenticated-orcid":true,"given":"Sebasti\u00e1n","family":"Fuentes-Retamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Gonz\u00e1lez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Guzm\u00e1n-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9706-5959","authenticated-orcid":true,"given":"Helena","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-1665","authenticated-orcid":true,"given":"Ulrike","family":"Kemmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"D\u00edaz-Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3934-6319","authenticated-orcid":true,"given":"Juan D.","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"pntd.0009978.ref001","volume-title":"Chagas disease (also known as American trypanosomiasis).","author":"World Health Organization","year":"2021"},{"issue":"Suppl 1","key":"pntd.0009978.ref002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed\u2014a background article","volume":"102","author":"JR Coura","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0009978.ref003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease.","volume":"391","author":"JA Perez-Molina","year":"2018","journal-title":"Lancet"},{"key":"pntd.0009978.ref004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American trypanosomiasis (Chagas disease).","volume":"33","author":"LE Echeverria","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"pntd.0009978.ref005","first-page":"e169","article-title":"Chagas Cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association","volume":"138","author":"MCP Nunes","year":"2018","journal-title":"Circulation"},{"key":"pntd.0009978.ref006","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","article-title":"The unsolved jigsaw puzzle of the immune response in Chagas disease.","volume":"9","author":"GR Acevedo","year":"2018","journal-title":"Front Immunol"},{"key":"pntd.0009978.ref007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of Chagas heart disease","volume":"14","author":"KM Bonney","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"pntd.0009978.ref008","doi-asserted-by":"crossref","first-page":"e0006814","DOI":"10.1371\/journal.pntd.0006814","article-title":"Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.","volume":"12","author":"CS Cardoso","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009978.ref009","doi-asserted-by":"crossref","first-page":"100694","DOI":"10.1016\/j.eclinm.2020.100694","article-title":"Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: a long-term follow up study.","volume":"31","author":"AM Hasslocher-Moreno","year":"2020","journal-title":"EClinicalMedicine"},{"key":"pntd.0009978.ref010","doi-asserted-by":"crossref","first-page":"1344.e1","DOI":"10.1016\/j.cmi.2018.06.006","article-title":"Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail","volume":"24","author":"C Crespillo-Andujar","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"pntd.0009978.ref011","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-018-0696-5","article-title":"Safety profile of benznidazole in the treatment of chronic Chagas disease: experience of a referral centre and systematic literature review with meta-analysis.","volume":"41","author":"C Crespillo-Andujar","year":"2018","journal-title":"Drug Saf"},{"key":"pntd.0009978.ref012","article-title":"Review of pharmacological options for the treatment of Chagas disease","author":"F Lascano","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"pntd.0009978.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","article-title":"Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology","volume":"58","author":"CN Serhan","year":"2017","journal-title":"Mol Aspects Med"},{"key":"pntd.0009978.ref014","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11745-004-1339-7","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers","volume":"39","author":"CN Serhan","year":"2004","journal-title":"Lipids"},{"key":"pntd.0009978.ref015","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"CN Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"pntd.0009978.ref016","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"YP Sun","year":"2007","journal-title":"J Biol Chem"},{"key":"pntd.0009978.ref017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"CN Serhan","year":"2014","journal-title":"Nature"},{"key":"pntd.0009978.ref018","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fmicb.2018.01961","article-title":"Inflammatory and pro-resolving lipids in trypanosomatid infections: a key to understanding parasite control","volume":"9","author":"RA Lopez-Munoz","year":"2018","journal-title":"Front Microbiol"},{"key":"pntd.0009978.ref019","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00436-013-3444-x","article-title":"Protection of vascular endothelium by aspirin in a murine model of chronic Chagas\u2019 disease","volume":"112","author":"A Molina-Berrios","year":"2013","journal-title":"Parasitol Res"},{"key":"pntd.0009978.ref020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exppara.2017.09.019","article-title":"Trypanosoma cruzi: Inhibition of infection of human monocytes by aspirin","volume":"182","author":"R Carvalho de Freitas","year":"2017","journal-title":"Exp Parasitol"},{"key":"pntd.0009978.ref021","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1128\/AAC.02752-14","article-title":"Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response","volume":"58","author":"AD Malvezi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009978.ref022","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1096\/fj.12-223982","article-title":"15-Epi-lipoxin A4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1","volume":"27","author":"T Carlo","year":"2013","journal-title":"FASEB J"},{"key":"pntd.0009978.ref023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2016.02.058","article-title":"Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas\u2019 heart disease","volume":"777","author":"H Ogata","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"pntd.0009978.ref024","doi-asserted-by":"crossref","first-page":"e00052","DOI":"10.1128\/IAI.00052-20","article-title":"Resolvin D1 administration is beneficial in Trypanosoma cruzi infection","volume":"88","author":"AL Horta","year":"2020","journal-title":"Infect Immun"},{"key":"pntd.0009978.ref025","first-page":"e02137","article-title":"Simvastatin attenuates endothelial activation through 15-epi-lipoxin A4 production in murine chronic Chagas cardiomyopathy","volume":"61","author":"F Gonzalez-Herrera","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009978.ref026","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"pntd.0009978.ref027","doi-asserted-by":"crossref","first-page":"ofz012","DOI":"10.1093\/ofid\/ofz012","article-title":"Progression of baseline electrocardiogram abnormalities in Chagas patients undergoing antitrypanosomal treatment.","volume":"6","author":"J Soverow","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"pntd.0009978.ref028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.gheart.2015.07.001","article-title":"Electrocardiogram and Chagas disease: a large population database of primary care patients","volume":"10","author":"MS Marcolino","year":"2015","journal-title":"Glob Heart"},{"key":"pntd.0009978.ref029","doi-asserted-by":"crossref","first-page":"e2173","DOI":"10.1371\/journal.pntd.0002173","article-title":"Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A(4)-mediated effect.","volume":"7","author":"A Molina-Berrios","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009978.ref030","doi-asserted-by":"crossref","first-page":"104427","DOI":"10.1016\/j.cellimm.2021.104427","article-title":"Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease.","volume":"369","author":"R das Dores Pereira","year":"2021","journal-title":"Cell Immunol"},{"key":"pntd.0009978.ref031","doi-asserted-by":"crossref","first-page":"893634","DOI":"10.1155\/2014\/893634","article-title":"The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice.","volume":"2014","author":"AM Canavaci","year":"2014","journal-title":"Mediators Inflamm"},{"key":"pntd.0009978.ref032","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.micinf.2010.03.016","article-title":"5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection","volume":"12","author":"WR Pavanelli","year":"2010","journal-title":"Microbes Infect"},{"key":"pntd.0009978.ref033","doi-asserted-by":"crossref","first-page":"ftv082","DOI":"10.1093\/femspd\/ftv082","article-title":"Immunity and immune modulation in Trypanosoma cruzi infection","volume":"73","author":"F Cardillo","year":"2015","journal-title":"Pathog Dis"},{"key":"pntd.0009978.ref034","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fmicb.2018.00553","article-title":"BALB\/c and C57BL\/6 mice cytokine responses to Trypanosoma cruzi infection are independent of parasite strain infectivity","volume":"9","author":"BL Ferreira","year":"2018","journal-title":"Front Microbiol"},{"key":"pntd.0009978.ref035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4049\/jimmunol.1003845","article-title":"IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection","volume":"188","author":"E Roffe","year":"2012","journal-title":"J Immunol"},{"key":"pntd.0009978.ref036","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182010001411","article-title":"In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85\/trans-sialidase family potentiates host infection","volume":"138","author":"RR Tonelli","year":"2011","journal-title":"Parasitology"},{"key":"pntd.0009978.ref037","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajpath.2012.03.042","article-title":"Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease","volume":"181","author":"L Esper","year":"2012","journal-title":"Am J Pathol"},{"key":"pntd.0009978.ref038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pim.12107","article-title":"Immunoregulatory networks in human Chagas disease","volume":"36","author":"WO Dutra","year":"2014","journal-title":"Parasite Immunol"},{"key":"pntd.0009978.ref039","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1161\/01.CIR.102.24.3003","article-title":"Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity","volume":"102","author":"FS Machado","year":"2000","journal-title":"Circulation"},{"key":"pntd.0009978.ref040","doi-asserted-by":"crossref","first-page":"38020","DOI":"10.1074\/jbc.M112.348599","article-title":"Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-alpha translation through a SHIP1-dependent pathway","volume":"287","author":"CS Chan","year":"2012","journal-title":"J Biol Chem"},{"key":"pntd.0009978.ref041","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.4049\/jimmunol.153.7.3135","article-title":"IL-10 mediates susceptibility to Trypanosoma cruzi infection","volume":"153","author":"SG Reed","year":"1994","journal-title":"J Immunol"},{"key":"pntd.0009978.ref042","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.4049\/jimmunol.174.5.2934","article-title":"Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL\/6 mice","volume":"174","author":"CF Anderson","year":"2005","journal-title":"J Immunol"},{"key":"pntd.0009978.ref043","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"SS Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"pntd.0009978.ref044","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pim.12183","article-title":"Interleukin-10 and tumour necrosis factor-alpha serum levels in chronic Chagas disease patients","volume":"37","author":"RH Vasconcelos","year":"2015","journal-title":"Parasite Immunol"},{"key":"pntd.0009978.ref045","doi-asserted-by":"crossref","first-page":"e87082","DOI":"10.1371\/journal.pone.0087082","article-title":"Plasma cytokine expression is associated with cardiac morbidity in chagas disease","volume":"9","author":"GR Sousa","year":"2014","journal-title":"PLoS One"},{"key":"pntd.0009978.ref046","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1128\/IAI.73.12.7960-7966.2005","article-title":"Type 1 chemokine receptor expression in Chagas\u2019 disease correlates with morbidity in cardiac patients","volume":"73","author":"JA Gomes","year":"2005","journal-title":"Infect Immun"},{"key":"pntd.0009978.ref047","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11033-020-06133-8","article-title":"Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro","volume":"48","author":"A Salas-Hernandez","year":"2021","journal-title":"Mol Biol Rep"},{"key":"pntd.0009978.ref048","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.taap.2014.03.017","article-title":"Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury","volume":"277","author":"J Chen","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"pntd.0009978.ref049","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1101305","article-title":"Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.","volume":"187","author":"AF Bento","year":"2011","journal-title":"J Immunol"},{"key":"pntd.0009978.ref050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","article-title":"Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease","volume":"9","author":"J Pirault","year":"2018","journal-title":"Front Pharmacol"},{"key":"pntd.0009978.ref051","first-page":"4037","article-title":"Resolvin D1 stimulates efferocytosis through p50\/p50-mediated suppression of tumor necrosis factor-alpha expression","volume":"126","author":"HN Lee","year":"2013","journal-title":"J Cell Sci"},{"key":"pntd.0009978.ref052","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.4049\/jimmunol.1700315","article-title":"Resolvin D1 improves the resolution of inflammation via activating NF-kappaB p50\/p50-mediated cyclooxygenase-2 expression in acute respiratory distress syndrome","volume":"199","author":"Y Gao","year":"2017","journal-title":"J Immunol"},{"key":"pntd.0009978.ref053","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","article-title":"Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway","volume":"111","author":"G Fredman","year":"2014","journal-title":"Proc Natl AcadSci USA"},{"key":"pntd.0009978.ref054","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1753425916628618","article-title":"Resolvin D1, resolvin D2 and maresin 1 activate the GSK3beta anti-inflammatory axis in TLR4-engaged human monocytes.","volume":"22","author":"Z Gu","year":"2016","journal-title":"Innate immun"},{"key":"pntd.0009978.ref055","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.167.6.3422","article-title":"Trypanocidal drug benznidazole impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription through inhibition of NF-kappaB activation","volume":"167","author":"E Piaggio","year":"2001","journal-title":"J Immunol"},{"key":"pntd.0009978.ref056","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","article-title":"Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain","volume":"6","author":"AC Cevey","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pntd.0009978.ref057","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations","volume":"49","author":"S Garcia","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009978.ref058","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/0074-02760160334","article-title":"Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial","volume":"112","author":"A Rassi","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0009978.ref059","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fimmu.2019.01267","article-title":"IL-10\/STAT3\/SOCS3 axis Is involved in the anti-inflammatory effect of benznidazole.","volume":"10","author":"AC Cevey","year":"2019","journal-title":"Front Immunol"},{"key":"pntd.0009978.ref060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2009.06.033","article-title":"Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas\u2019 heart disease","volume":"145","author":"CM Ribeiro","year":"2010","journal-title":"Int J Cardiol"},{"key":"pntd.0009978.ref061","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"BS Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009978.ref062","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy","volume":"373","author":"CA Morillo","year":"2015","journal-title":"N Engl J Med"},{"key":"pntd.0009978.ref063","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2016.10.098","article-title":"Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.","volume":"227","author":"LE Echeverria","year":"2017","journal-title":"Int J Cardiol"},{"key":"pntd.0009978.ref064","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bjid.2020.08.007","article-title":"Role of FAK signaling in chagasic cardiac hypertrophy","volume":"24","author":"AR Tucci","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"pntd.0009978.ref065","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1371\/journal.pntd.0002034","article-title":"Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes.","volume":"7","author":"RS Corral","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009978.ref066","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1128\/IAI.71.8.4441-4447.2003","article-title":"Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy","volume":"71","author":"CA Petersen","year":"2003","journal-title":"Infect Immun"},{"key":"pntd.0009978.ref067","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"V Kain","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"pntd.0009978.ref068","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2015.07.076","article-title":"LXA4 actions direct fibroblast function and wound closure","volume":"464","author":"BS Herrera","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"pntd.0009978.ref069","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13071-018-2614-1","article-title":"Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins","volume":"11","author":"LL Coelho","year":"2018","journal-title":"Parasit Vectors"},{"key":"pntd.0009978.ref070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.CIR.0000079174.13444.9C","article-title":"Prognostic value of QT interval parameters for mortality risk stratification in Chagas\u2019 disease: results of a long-term follow-up study","volume":"108","author":"G Salles","year":"2003","journal-title":"Circulation"},{"key":"pntd.0009978.ref071","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1645\/GE-2396.1","article-title":"ECG detection of murine chagasic cardiomyopathy","volume":"96","author":"CS Eickhoff","year":"2010","journal-title":"J Parasitol"},{"key":"pntd.0009978.ref072","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3389\/fimmu.2017.01863","article-title":"Efferocytosis of pathogen-infected cells.","volume":"8","author":"N Karaji","year":"2017","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009978","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T05:08:50Z","timestamp":1673759330000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009978"}},"subtitle":[],"editor":[{"given":"Helton da Costa","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009978","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.17.456695","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}